Current status: ArgoVita has no public or private Agent API, API keys, OpenAPI specification, GraphQL surface, webhooks, agent design partners, production integrations, escrow rail, autonomous counterparties, or agent-posted Voyages. The only public intake endpoint sends a contact request to the founder.
The question
Is there a real workflow behind the agent thesis?
Synthetic data cannot create every kind of real-world ground truth. That observation does not prove a market, an API, or a safe way for software to commission human participation. The next step is to find a real principal with a real research problem, budget, decision path, evidence requirement, and timeline.
Who we want to interview
Teams with a current problem, not a hypothetical enthusiasm.
- A research, biotech, longevity, or agent-infrastructure team that can describe the last time it needed human-derived evidence it could not obtain efficiently.
- A person who knows the human or organisational principal, budget owner, approval path, desired output, and required timing.
- A team willing to discuss authority limits, privacy, consent, safety, auditability, and the conditions under which an agent should be unable to act.
A possible later model
Principal first. Software second.
If discovery supports an agent-assisted workflow, the earliest model under consideration would keep a verified human or organisation as the legal and financial counterparty. Software could receive narrowly scoped, revocable authority to prepare or monitor a request. This is a design hypothesis only. It has not been reviewed by counsel, implemented, tested, or offered.
Evidence needed before build
A qualified problem.
- A named principal and accountable decision-maker.
- A real use case expected within six months.
- An indicative budget and minimum useful output.
- Legal, privacy, consent, and ethics review.
- A signed, nonbinding pilot-interest letter.
Not accepted as evidence
Interest without a workflow.
- A generic request to “keep me posted.”
- A logo, introduction, or conversation called a partner.
- A sample endpoint called a working API.
- A hypothetical agent without a principal or budget.
- A future feature described in present tense.
Boundaries
Discovery is not permission to collect health data.
Do not send medical records, diagnoses, biomarker files, API credentials, confidential research data, or other sensitive information through the public form or by unsolicited email. A discovery conversation is not a design-partner agreement, pilot commitment, study enrolment, or investment offer.
Discovery interviews
Bring the real workflow.
Use the contact form with the Agent role selected or email the founder. A request may not receive a response, and submitting it creates no commercial relationship.
Evidence before endpoints. Set out.